2.4 Scope of Work The OFFEROR shall provide a report covering analyses described below. OMCCR may provide anonymized information on patient access to medical cannabis that have been 13 collected in past surveys or recorded in the program’s seed-to-sale database. However, the OFFEROR is responsible for gathering its own market data and obtaining any required Institutional Review Board clearances. 2.4.1 The OFFEROR shall evaluate qualifying patients’ access to medical cannabis and access barriers under the current medical cannabis dispensary licensing regulatory framework, to include: a. Current and future size of the medical cannabis market for the next five years and the optimal amount of cannabis production to meet current and future needs b. Current cost of medical cannabis, including patient expenditures across product categories, regulated market and gray/illicit market price comparison, and wholesale and retail prices across product categories compared to similar jurisdictions c. Access to medical providers and to licensed medical cannabis dispensaries, including a comparison of dispensary population and travel distance to nearest dispensaries d. Effects of regulations, such as maximum monthly allotment, plant count restrictions and caregiver cultivation restrictions, on patient’s access to medical cannabis e. Other barriers to access as relevant to the medical cannabis program 2.4.2 The OFFEROR shall conduct an evaluation of the economic impact of Hawaii’s current regulatory framework on the viability of licensed dispensaries with respect to the following: a. Taxation, licensing fees, and annual renewal fees b. Ongoing regulatory requirements such as seed-to-sale tracking, security systems, inventory management, and testing protocols c. Limited patient base (and required number of patients to purchase from dispensaries) d. Regulations restricting product diversity e. Size of the gray and illicit markets, including cannabis cultivation farms and hemp retailers, and their impact on dispensary sales f. Impact of the home cultivations, particularly the application of caregiver cultivation, on dispensary viability g. Other factors that may impose challenges
